Independent drug stores hold their own in Rx market
More often than not, independent drug stores are overshadowed by the big retail chains.
Opinion
Health@250: America at a crossroads
The impact of a healthy population and vibrant workforce on the ability of the economy to sustain growth should not be underestimated.
NASP hails House action on retroactive Part D fees
The National Association of Specialty Pharmacy (NASP) has commended 54 members of the House of Representatives for urging federal agencies to eliminate retroactive Medicare Part D fees charged by big pharmacy benefit managers.
Retail Rx gets out ahead of Amazon
Speculation about the possible entry of Amazon into the prescription drug business has been abundant in recent weeks.
Consumers@250: Future of chain drug retailing
at least at times — might appear to be the disruptive chaos of today’s market.
Boots adapts its strategy with Farmacias Benavides
To quote one of Cortes’ officers when the Spanish first arrived in Mexico, they came “to serve God and His Majesty and also to get riches.” While the Boots/Walgreens story was playing out in the U.S.
Chain drug industry looks ahead at uncertain future
as much for the uncertainty of the future as for the problems of the past. As November ended and December began, the National Association of Chain Drug Stores brought industry leaders together in New York City for NACDS Week in
Value of NACDS evident as new era dawns
At the start of the month the National Association of Chain Drug Stores concluded a series of successful events in the nation’s economic and cultural capital.
In Rx, ounce of prevention worth pound of cure
A regulatory inspection by the Drug Enforcement Administration or a state board of pharmacy can be a high stakes event.
Old retailing order gives way to new future
As the year nears its end, surprises continue to make news in chain drug retailing. Mostly, negative surprises. Earlier this month, CVS downsized its headquarters staff by some 600 employees, stopping for a moment the retailer’s uninterrupted string of good news.
There’s still a lot of life left in trade shows
The Food Marketing Institute’s recent cancellation of FMI Connect, the trade show that had been scheduled for McCormick Place in Chicago next June, raises some interesting questions about the value and long-term viability of such events.
Drug chains’ beauty business in doldrums
In chain drug retailing, the most disappointing product category in 2016 has been beauty care. Indeed, the problem with the beauty care category in chain drug stores is, quite simply, the chain drug store’s inability to generate any significant interest in the category.
WBA’s efforts recognized by the UN Foundation
The United Nations Foundation last month recognized five individuals and organizations whose support has helped the UN address a range of serious issues around the globe.
Time for population health management model
Our nation’s health care industry is under tremendous pressure to change in order to make quality health care delivery more affordable and accessible. Escalating costs are shifting our health care economy from traditional fee-for-service to value-based payment models.
In retailing, change is now the only constant
In the early 1960s, Bob Dylan, who was just awarded the Nobel Prize in Literature, asked his listeners to “… admit that the waters/Around you have grown/And accept it that soon you be drenched to the bone/If your time to you is worth savin’/Then you better start swimmin’ or you’ll sink like a stone/
It’s time for drug chains to shake things up
indeed, three months have passed since the NACDS Total Store Expo gathered the industry together in Boston. Against that background, the NACDS year-end meetings, scheduled for New York City following